News
News
- Addex ADX71149 Receives IND Approval to Start a Phase 2a Clinical Study in Epilepsy
07:00 - GlobeNewswire - FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of QS, PEN and SWI
01/20/2021 / 04:34 - GlobeNewswire - FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of BSX and SPLK
01/20/2021 / 04:26 - GlobeNewswire - FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of BSX, QS, SPLK and SWI
01/13/2021 / 04:50 - GlobeNewswire - Addex to Present at the Baader Helvea Swiss Equities Conference
01/12/2021 / 07:00 - GlobeNewswire - Addex Successfully Completes $11.5 Million Capital Increase Including Full Exercise of Underwriter’s Option to Purchase Additional Securities
01/11/2021 / 22:00 - GlobeNewswire - FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of BSX and SPLK
01/06/2021 / 04:30 - GlobeNewswire - Four Top Psychedelic Stock Picks for 2021
01/04/2021 / 14:00 - GlobeNewswire - S. Korea eyes V-shaped recovery for 2021 - FinMin
12/31/2020 / 07:59 - TeleTrader - Ealixir Inc. Enters Into Agreement With Milan Association of Chartered Accountants to Provide Digital Identity Services
12/30/2020 / 17:04 - GlobeNewswire
Real-time